These issues are thought to arise from hypokalemia’s detrimental impact on pancreatic β-cell responsiveness to hyperglycemia and its interference with insulin secretion (Sun et al., 2014; Zhang et al., 2018; Hall et al., 2020). The gene discussed is INS; the disease is Hyperglycemia.